Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire.

OBJECTIVE The objective of this study was to develop a valid and reliable health-related quality of life (HRQOL) questionnaire for use in multinational clinical trials of patients with type I and type II diabetes. METHODS Through patient focus groups and expert clinician panels in the United States (US) and France, relevant HRQOL domains for patients with type I and type II diabetes were identified. A draft questionnaire was developed by including validated, widely used generic and diabetes-specific domains and by developing original questions as required. A pilot study (n = 123) was conducted to evaluate the psychometric properties of the draft questionnaire with revisions being subsequently made. Data collected from two multinational clinical trials of patients with type I and type II diabetes were used to further validate and enhance the questionnaire (DQLCTQ). RESULTS A total of 942 patients were recruited in the clinical trials from Canada, France, Germany, and the United States. The mean age was 33.8 years for patients with type I diabetes (n = 468) and 58.2 years for patients with type II diabetes (n = 474). The mean HbAlc level at baseline was 8.6. The revised version of the questionnaire (DQLCTQ-R) contains a total of 57 questions comprising 8 generic and disease-specific domains, as follows: Physical Function; Energy/Fatigue; Health Distress; Mental Health; Satisfaction; Treatment Satisfaction; Treatment Flexibility; and Frequency of Symptoms. Intraclass correlation coefficients range from 0.74 to 0.90 and Cronbach's alphas range from 0.77 to 0.90. With very few exceptions, all eight domains were able to discriminate between type I and type II diabetes, tight and poor metabolic control, male and female, and good and poor self perceived control of diabetes. Four domains (Treatment Satisfaction, Health/Distress, Mental Health, and Satisfaction) were responsive to clinical change in metabolic control. CONCLUSION The DQLCTQ-R is a reliable, valid, and comprehensive HRQOL instrument. It is suitable in multinational clinical trials to evaluate new or alternative treatments for patients with type I and type II diabetes.

[1]  R. Brook.  Studies of process-outcome correlations in medical care evaluations. , 1979, Medical care.

[2]  D. Streiner,et al.  Health Measurement Scales: A practical guide to thier development and use , 1989 .

[3]  W. Gregory,et al.  Who should measure quality of life, the doctor or the patient? , 1988, British Journal of Cancer.

[4]  P. Gertman,et al.  Utilization review in the United States: results from a 1976-1977 national survey of hospitals. , 1979, Medical care.

[5]  G Nowacek,et al.  Fear of Hypoglycemia: Quantification, Validation, and Utilization , 1987, Diabetes Care.

[6]  D. Patrick,et al.  Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation , 1993 .

[7]  T. R. Taylor,et al.  Disease-specific Versus Generic Measurement of Health-related Quality of Life in Insulin-dependent Diabetic Patients , 1993, Medical care.

[8]  C. Bradley,et al.  Guidelines for Encouraging Psychological Well‐being , 1994 .

[9]  G. Klerman,et al.  The effects of antihypertensive therapy on the quality of life. , 1986, The New England journal of medicine.

[10]  L. Cronbach.  Coefficient alpha and the internal structure of tests , 1951 .

[11]  C. Agardh,et al.  The influence of different insulin regimens on quality of life and metabolic control in insulin-dependent diabetics. , 1989, Diabetes research and clinical practice.

[12]  G. Albrektsen,et al.  Self-assessed Quality of Life and Metabolic Control in Persons with Insulin-Dependent Diabetes Mellitus (IDDM) , 1991, Scandinavian journal of social medicine.

[13]  D. Nerenz,et al.  Ongoing assessment of health status in patients with diabetes mellitus. , 1992, Medical care.

[14]  L. Vignati,et al.  Health-Related Quality-of-Life Results From Multinational Clinical Trials of Insulin Lispro: Assessing benefits of a new diabetes therapy , 1997, Diabetes Care.

[15]  A. Stewart,et al.  Measuring Functioning and Well-Being: The Medical Outcomes Study Approach , 1992 .

[16]  D. Dillman,et al.  Mail and telephone surveys , 1978 .

[17]  S. Pocock.  A perspective on the role of quality-of-life assessment in clinical trials. , 1991, Controlled clinical trials.

[18]  D. Lucido,et al.  Psychological and Social Correlates of Glycemic Control , 1984, Diabetes Care.

[19]  R A Deyo,et al.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. , 1991, Controlled clinical trials.